Rankings
▼
Calendar
MRVI FY 2025 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$999M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$186M
-28.3% YoY
Gross Profit
$33M
18.0% margin
Operating Income
-$7M
-3.6% margin
Net Income
-$131M
-70.4% margin
EPS (Diluted)
$-0.91
Cash Flow
Operating Cash Flow
-$58M
Free Cash Flow
-$71M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$771M
Total Liabilities
$398M
Stockholders' Equity
$212M
Cash & Equivalents
$217M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$186M
$259M
-28.3%
Gross Profit
$33M
$108M
-69.2%
Operating Income
-$7M
-$236M
+97.1%
Net Income
-$131M
-$145M
+9.7%
← Q4 2024
All Quarters
Q1 2025 →